Compounding Pharmacies Market Size, Share, Growth Report 2032

The global compounding pharmacies market size was worth around USD 13.23 billion in 2023 and is predicted to grow to around USD 21.06 billion by 2032 with a compound annual growth rate (CAGR) of roughly 5.30% between 2024 and 2032.

The report covers the forecast and analysis for the compounding pharmacies market on a global and regional level. The study provides historic data for 2018 and 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion).
Request Free Sample

Compounding Pharmacies Market: Overview

The pharmacies which produce the drugs tailored to the individual patient needs, based on the doctor’s or physician’s prescription are called compound pharmacies. Compounded drugs are the amalgamation of two or more drug ingredients in different proportions, i.e., combining or altering the active pharmaceutical ingredients of drugs to meet the unmet medical need of an individual patient.  The major driver of compounding pharmacies market is worldwide increasing geriatric population. The population aged 60 or above is growing rapidly thus the demand for anti-aging products which use custom compounded drugs are increasing. The compounding medicines are made as per the required dose and concentration as per patient need. Moreover, the ease of administering compounded drugs is particularly distinguished in critical illnesses such as cancer, where a patient is incapable to swallow a pain-reducing drug. The drug is either administered as a transdermal application, lollipop, or sterile preparation. The high advantages of compounded drugs over commercial medicines on an individual patient will propel the market during the forecast period.

These drugs formation process is carried out under the supervision of licensed medical practitioners or pharmacist. However, compounded medications are not approved by many regulatory authorities globally owing to its safety and effectiveness concerns. Compounded medications are not FDA approved. Furthermore, these drugs are mostly not reimbursed by pharmaceutical benefit agencies, which may hamper the growth of the global compounding pharmacies market in the near future.

The study includes drivers and restraints for the compounding pharmacies market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the compounding pharmacies market on a global level.

In order to give the users of this report a comprehensive view of the compounding pharmacies market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein the product type segment, therapeutic segment, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

Compounding Pharmacies Market: Segmentation

The study provides a decisive view of the compounding pharmacies market by segmenting the market based on product type, therapeutic type, end-users, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024.

On the basis of product type the global compounding pharmacies market is segmented into oral, topical, mouthwashes, suppositories, injectables, and ophthalmic. The oral product type is further segmented into capsules, tablets, suspension, lozenges, and lollipops. The topical products are further classified into creams, gels, ointments, and lotions. The injectables segment is sub-segmented into injections, infusions, concentrates, powders for reconstitution, and gels. Among which oral product segment dominates the market, owing to the convenience of oral medication, safe, and non-invasive route of administration, which will increase the patient preference for oral medications thus fueling the growth of oral segment during the forecast period.

Based on the therapeutic type, the market is segmented into hormone replacement and pain management category.

The end-users are classified into an adult, pediatric, geriatric, and veterinary.

Compounding Pharmacies Market: Report Scope

Compounding Pharmacies Market: Regional Analysis

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., Rest of North America, the U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of the Middle East and Africa. This segmentation includes demand for compounding pharmacies market based on individual product type, therapeutic type, and end-users in all the regions and countries.

North America held a dominant share for the global market for compounding pharmacies in 2017 and region is projected to continue with its regional supremacy in the forthcoming years as well. The growth of this regional market is attributed with the favorable government policies, high acceptance of compounded drugs, and increasing number of compounding pharmacies in the region. Asia Pacific is projected to grow at a significant CAGR due to rising healthcare infrastructure. Moreover, increase in the research & development activities with regards to improvement in the several healthcare outcomes and to obtain more accurate and precise results will propel the growth of the compounding pharmacies market in Asia Pacific region. Increasing incidences of chronic disorders and augmentation in the geriatric population will also increase the burden on the healthcare economy and will drive the market during the forecast period.

Compounding Pharmacies Market: Competitive Analysis

• AmerisourceBergen
• Rx3 Pharmacy
• Agbi’s Sterile Compounding Pharmacy LLC
• B. Braun Medical Inc.
• Cantrell Drug Company Inc.
• Belle Sante Diagnostic & Therapeutic Institute Pvt. Ltd.
• Village Sterile Compounding Pharmacy
• Imprimis Pharmaceuticals Inc.
• Institutional Pharmacies Of Louisiana LLC
• Lorraine's Pharmacy
• McGuff Sterile Compounding Pharmacy Services Inc.
• Panaceutics Inc.
• Pencol Compounding Pharmacy
• Fagron
• ITC Compounding Pharmacy
• SCA Pharmaceuticals
• Wedgewood Pharmacy
• Fresenius Kabi AG
• Dougherty's Holdings Inc.

The global compounding pharmacies market is segmented as follows:

By Product Type 

• Oral 
• Topical
• Mouthwashes
• Suppositories
• Injectables
• Ophthalmic

By Therapeutic Type 

• Hormone Replacement 
• Pain Management 

By End-user

• Adult
• Pediatric
• Geriatric
• Veterinary

By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa